Postgrad LIVE! Study Fairs

Southampton | Bristol

Nottingham Trent University Featured PhD Programmes
University of Warwick Featured PhD Programmes
Anglia Ruskin University Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes

PhD in Clinical Cardiology: Improving management of atrial fibrillation and heart failure

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

We are offering an opportunity for an excellent candidate to apply for a 3 year PhD studentship. The student must be self-funding and able to pay for tuition fees, living costs and consumables (no grants for this position are currently available).

The Institute of Cardiovascular Sciences at the University of Birmingham is a world-leader in research targeting the management of patients with heart failure, atrial fibrillation and the combination of these conditions. We have a diverse research portfolio, ranging from basic science exploration of cellular responses, translational studies, clinical trials, cardiac imaging (echocardiography and cardiac magnetic resonance imaging) and systematic review.

For more information about the research group and the Institute of Cardiovascular Sciences please visit: and

Minimum entry requirements for applicants:
1. Medically qualified with the ability to practice medicine in the UK according to General Medical Council requirements
2. Extensive information technology skills
3. Fluent in the English language

Desirable skills:
1. Experience in Cardiology
2. Familiarity with the use of statistical software such as Stata, or evidence that the candidate is currently studying this aspect (for example, local courses or the free online “UCLA Stata Starter Kit”)
3. Experience in cardiac imaging (echocardiography and cardiac magnetic resonance imaging)
4. Experience in data management

PhD project:
The specific project can be designed to suit the applicant, most likely including large patient datasets available at the Institute of Cardiovascular Sciences in Birmingham (see link to recent publications below), cardiovascular trials and/or cardiac imaging studies.

To apply, please submit your CV, a covering letter, a detailed project proposal and confirmation of funding/self-funding status.

Funding Notes

Self-funded applicants only (all applicants should indicate in their applications how they intend to fund their studies), with a high-level command of the English language as outlined in the postgraduate prospectus. Further details available here: View Website


Recent research findings and publications can be reviewed at:

Kotecha D*, Mohammed M, Shantsila E, Popescu BA, Steeds RS. Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review. Europace. 2017; in press; DOI: 10.1093/europace/eux027. PMID: TBC.
Lane DA*, Skøjth F, Larsen TB, Lip GYH, Kotecha D. Temporal trends in atrial fibrillation incidence, comorbidity and mortality: comprehensive linked data from primary care. J Am Heart Assoc. 2017; in press. PMID: TBC.
Kotecha D*, Ahmed A, Calvert M, Lencioni M, Terwee C, Lane DA. Evaluation of patient-reported outcomes for quality of life assessment in atrial fibrillation: A systematic review. PLOS one. 2016;11:e0165790. PMID: 27802324.
Kotecha D, Lam CS, van Veldhuisen DJ, van Gelder IC, Voors AA, Rienstra M*. Vicious Twins - Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation. J Am Coll Cardiol. 2016;68:2217-28. PMID: 27855811.
Kirchhof P*, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:2893-2962. PMID: 27567408.

Kotecha D*, Manzano L, Packer M, et al. Age and gender differences in treatment efficacy and tolerability: The Beta-blockers in Heart Failure Collaborative Group. BMJ. 2016;353:i1855. PMID: 27098105.
Kotecha D*, Chudasama R, Lane DA, Kirchhof P, Lip GYH. Atrial fibrillation and heart failure: A systematic review and meta-analysis of clinical outcomes in reduced versus preserved ejection fraction. Int J Cardiol. 2016;203:660-6. PMID: 26580351.
Kotecha D*, Piccini JP. Atrial fibrillation in heart failure. What should we do? Eur Heart J. 2015;46:3250-7. PMID: 26419625.

Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, Steeds RP, Townend J, Kotecha D*. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015;351:h4451. PMID: 26321114.
Senoo K, Lip GYH*, Lane DA, Büller HR, Kotecha D. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial. Stroke. 2015;46:2523-8. PMD: 26205373.
Kotecha D*, Holmes J, Krum H, Altman DG, Manzano L, Cleland JGF, Lip GYH, Coats AJS, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014;384:2235-2243. PMID: 25193873.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.